These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 32661627)
1. Pentraxin-3 and adropin as inflammatory markers of early renal damage in type 2 diabetes patients. Li B; Tian X; Guo S; Zhang M; Li J; Zhai N; Wang H; Zhang Y Int Urol Nephrol; 2020 Nov; 52(11):2145-2152. PubMed ID: 32661627 [TBL] [Abstract][Full Text] [Related]
2. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin. Wu C; Wang Q; Lv C; Qin N; Lei S; Yuan Q; Wang G Diabetes Res Clin Pract; 2014 Nov; 106(2):343-50. PubMed ID: 25263500 [TBL] [Abstract][Full Text] [Related]
3. The Clinical Value of Serum Adropin Level in Early Detection of Diabetic Nephropathy. Es-Haghi A; Al-Abyadh T; Mehrad-Majd H Kidney Blood Press Res; 2021; 46(6):734-740. PubMed ID: 34644709 [TBL] [Abstract][Full Text] [Related]
4. Association of serum pentraxin 3 concentrations with diabetic nephropathy. Wang R; Zhang J; Hu W J Investig Med; 2016 Aug; 64(6):1124-7. PubMed ID: 27233528 [TBL] [Abstract][Full Text] [Related]
5. Serum angiopoietin-2: a promising biomarker for early diabetic kidney disease in children and adolescents with type 1 diabetes. Salem NA; Ismail WM; Hendawy SR; Abdelrahman AM; El-Refaey AM Eur J Pediatr; 2024 Sep; 183(9):3853-3862. PubMed ID: 38884820 [TBL] [Abstract][Full Text] [Related]
6. Effect of renin angiotensin system blockade on pentraxin 3 levels in type-2 diabetic patients with proteinuria. Yilmaz MI; Axelsson J; Sonmez A; Carrero JJ; Saglam M; Eyileten T; Caglar K; Kirkpantur A; Celik T; Oguz Y; Vural A; Yenicesu M; Lindholm B; Stenvinkel P Clin J Am Soc Nephrol; 2009 Mar; 4(3):535-41. PubMed ID: 19211665 [TBL] [Abstract][Full Text] [Related]
7. Expression levels of serum vasohibin-1 and other biomarkers in type 2 diabetes mellitus patients with different urinary albumin to creatinine ratios. Ren H; Shao Y; Ma X; Yang M; Liu Y; Wang Q J Diabetes Complications; 2019 Jul; 33(7):477-484. PubMed ID: 31097304 [TBL] [Abstract][Full Text] [Related]
8. Diabetic Nephropathy Can Be Treated with Calcium Dobesilate by Alleviating the Chronic Inflammatory State and Improving Endothelial Cell Function. Zhou Y; Qi C; Li S; Shao X; Mou S; Ni Z Cell Physiol Biochem; 2018; 51(3):1119-1133. PubMed ID: 30476916 [TBL] [Abstract][Full Text] [Related]
10. NLRP3 expression and urinary HSP72 in relation to biomarkers of inflammation and oxidative stress in diabetic nephropathy patients. El-Horany HE; Abd-Ellatif RN; Watany M; Hafez YM; Okda HI IUBMB Life; 2017 Aug; 69(8):623-630. PubMed ID: 28631886 [TBL] [Abstract][Full Text] [Related]
11. PTPN2 Downregulation Is Associated with Albuminuria and Vitamin D Receptor Deficiency in Type 2 Diabetes Mellitus. Zheng L; Zhang W; Li A; Liu Y; Yi B; Nakhoul F; Zhang H J Diabetes Res; 2018; 2018():3984797. PubMed ID: 30246029 [TBL] [Abstract][Full Text] [Related]
12. Association between neutrophil-to-lymphocyte ratio and diabetic kidney disease in type 2 diabetes mellitus patients: a cross-sectional study. Li X; Wang L; Liu M; Zhou H; Xu H Front Endocrinol (Lausanne); 2023; 14():1285509. PubMed ID: 38239986 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of serum levels of sestrin 2 and betatrophin in type 2 diabetic patients with diabetic nephropathy. Emara AM; El Bendary AS; Ahmed LM; Okda HI BMC Nephrol; 2024 Jul; 25(1):231. PubMed ID: 39030467 [TBL] [Abstract][Full Text] [Related]
14. The unique association between the level of plateletcrit and the prevalence of diabetic kidney disease: a cross-sectional study. Wei S; Pan X; Xiao Y; Chen R; Wei J Front Endocrinol (Lausanne); 2024; 15():1345293. PubMed ID: 38726343 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the association of plasma pentraxin 3 levels with type 2 diabetes and diabetic nephropathy in a Malay population. Abu Seman N; Witasp A; Wan Mohamud WN; Anderstam B; Brismar K; Stenvinkel P; Gu HF J Diabetes Res; 2013; 2013():298019. PubMed ID: 24350299 [TBL] [Abstract][Full Text] [Related]
16. Levels of Serum 25(OH)VD3, HIF-1α, VEGF, vWf, and IGF-1 and Their Correlation in Type 2 Diabetes Patients with Different Urine Albumin Creatinine Ratio. Shao Y; Lv C; Yuan Q; Wang Q J Diabetes Res; 2016; 2016():1925424. PubMed ID: 27069929 [TBL] [Abstract][Full Text] [Related]
17. E-cadherin and periostin in early detection and progression of diabetic nephropathy: epithelial-to-mesenchymal transition. El-Dawla NMQ; Sallam AM; El-Hefnawy MH; El-Mesallamy HO Clin Exp Nephrol; 2019 Aug; 23(8):1050-1057. PubMed ID: 31104272 [TBL] [Abstract][Full Text] [Related]
18. The changes in miR-130b levels in human serum and the correlation with the severity of diabetic nephropathy. Lv C; Zhou YH; Wu C; Shao Y; Lu CL; Wang QY Diabetes Metab Res Rev; 2015 Oct; 31(7):717-24. PubMed ID: 25952368 [TBL] [Abstract][Full Text] [Related]
19. Elevated plasma pentraxin 3 levels are associated with development and progression of diabetic retinopathy in Korean patients with type 2 diabetes mellitus. Yang HS; Woo JE; Lee SJ; Park SH; Woo JM Invest Ophthalmol Vis Sci; 2014 Aug; 55(9):5989-97. PubMed ID: 25159210 [TBL] [Abstract][Full Text] [Related]
20. Relationship between bone turnover markers and renal disease in elderly patients with type 2 diabetes: a cross-sectional study. Wei S; Pan X; Wei J BMC Endocr Disord; 2024 Sep; 24(1):179. PubMed ID: 39237970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]